About
Advanced Biomed Inc. Common Stock (NASDAQ:ADVB) — investor relations, events, news, and company updates on 6ix.
Latest News
Feb 18 2026
Advanced Biomed Inc. Announces 1 for 20 Share Consolidation
Feb 13 2026
Advanced Biomed Inc. Announces 120‑Case Feasibility Study with Chi‑Mei Medical Center to Validate A+PerfusC™ – Integrated Perfusion 3D Cell Culture Platform for Precision Medicine and Drug Discovery
Dec 30 2025
Advanced Biomed Inc. Announces Disposal of its Hong Kong Subsidiary
Dec 30 2025
Advanced Biomed Inc. Announces Disposal of its Hong Kong Subsidiary
Sep 19 2025
Advanced Biomed Inc. Announces Launch of A+PerfusC™ – Integrated Perfusion 3D Cell Culture Platform for Precision Medicine and Drug Discovery
Financials
Revenue
$0
Market Cap
$6.03 M
P/E Ratio
1.26
EPS
3.52
Translate